Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Hotel Properties

4.30
+0.02000.47%
Post-market: 4.300.00000.00%16:04 EDT
Volume:1.05M
Turnover:4.52M
Market Cap:469.91M
PE:21.21
High:4.43
Open:4.37
Low:4.27
Close:4.28
Loading ...

Summit Hotel Properties Q4 Revpar USD 117.21

THOMSON REUTERS
·
25 Feb

Summit Hotel Properties Inc Outlook FY25 Adjusted Ffo per Share of Common Stock and Common Units $0.90- $1.00

THOMSON REUTERS
·
25 Feb

Summit Hotel Properties Inc FY2025 Ffo Shr View $0.97 -- Lseg Ibes Data

THOMSON REUTERS
·
25 Feb

Summit Hotel Properties Q4 Net Income USD 680 Thousand

THOMSON REUTERS
·
25 Feb

Actinogen reports busy 6 months as development of Xanamem molecule ramps up

The Market Herald
·
24 Feb

Summit Hotel Properties Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
22 Feb

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

Zacks
·
20 Feb

Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis

GlobeNewswire
·
19 Feb

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

GlobeNewswire
·
18 Feb

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts

Insider Monkey
·
17 Feb

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

CNW Group
·
11 Feb

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

PR Newswire
·
05 Feb

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

CNW Group
·
30 Jan

BofA Securities Adjusts Summit Hotel Properties Price Target to $7 From $6.50

MT Newswires Live
·
27 Jan

Summit Hotel Properties Keeps Quarterly Dividend at $0.08 a Share, Payable Feb. 28 to Holders of Record Feb. 14

MT Newswires Live
·
24 Jan

Press Release: SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS

Dow Jones
·
24 Jan

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

GlobeNewswire
·
10 Jan

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE

PR Newswire
·
10 Jan

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

CNW Group
·
10 Jan

SELLAS Announces Key Business Objectives for 2025

GlobeNewswire
·
08 Jan